Clinical trials: Hypoventilation Syndrome

Congenital Central Hypoventilation Syndrome

Therapeutic Effect of Desogestrel on Ventilatory Control in Patients With Congenital Central Hypoventilation Syndrome

• Terminated
• Age: 16 to 50 years
• Phase 2
• Results posted

Background: Congenital Central Hypoventilation Syndrome (CCHS) is a rare disorder of automatic control of breathing. This disease can manifest as early as birth.

Trial name

NCT01500473

Testing

Desogestrel

Where

United States

Volunteers

1 people

Sponsor

Children's Hospital Los Angeles